NCT00241995

Brief Summary

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 19, 2005

Completed
Last Updated

October 18, 2006

Status Verified

October 1, 2005

First QC Date

October 17, 2005

Last Update Submit

October 17, 2006

Conditions

TopiramateLamotrigineMemnatineDiazepamPlacebo

Interventions

AnticonvulsantsDRUG

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Alcohol dependence Alcohol withdrawal syndrome

You may not qualify if:

  • Drug dependence Major psychiatric diagnoses Severe somatic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Anticonvulsants

Intervention Hierarchy (Ancestors)

Central Nervous System AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Officials

  • Evgeny M Krupitsky, MD, PhD

    St. Petersburg State Pavlov Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 17, 2005

First Posted

October 19, 2005

Last Updated

October 18, 2006

Record last verified: 2005-10